TANDEM DIABETES CARE INC (TNDM) insider trading

By person

25 insiders · 376 transactions

3.8×

John Sheridan holds only 3.8 times base salary in stock. $3.07M of shares against $790.58K in salary for 2025.

Salary from the company's own proxy. The shares are what John Sheridan last reported holding, valued at $19.15, the price Common Stock was last bought or sold at on the open market here, on 27 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kim D Blickenstaff

Director

$4.50M (3)

$149.33M (61)

−$144.83M

970,021

1.39%

$18.58M

—

Brian B Hansen

EVP & Chief Commercial Officer

—

$25.00M (30) scheduled

−$25.00M

12,622

0.0181%

$241.71K

—

Douglas A Roeder

Director

$2.00M (2)

$25.78M (12)

−$23.78M

1,007,863

1.45%

$19.30M

−26.3%

Susan Morrison

EVP & Chief Admin. Officer

—

$18.79M (14) scheduled

−$18.79M

52,788

0.0759%

$1.01M

—

Leigh Vosseller

EVP & Chief Financial Officer

$530.13K (6)

$17.00M (26) scheduled

−$16.47M

77,910

0.1120%

$1.49M

+6,453%

David B Berger

EVP & Chief Operating Officer

—

$15.73M (50) scheduled

−$15.73M

8,273

0.0119%

$158.43K

+97.6%

John F Sheridan

President & CEO

$277.07K (2)

$14.15M (22) scheduled

−$13.87M

160,260

0.2303%

$3.07M

+20,499%

Dick Allen

Chair Emeritus

$608.68K (9)

$6.78M (29)

−$6.17M

57,038

0.0820%

$1.09M

+144.2%

Christopher J Twomey

Director

$150.00K (2)

$5.32M (23)

−$5.17M

44,682

0.0642%

$855.66K

+276.2%

Elizabeth Anne Gasser

EVP, Chief Strategy Officer

—

$3.37M (4) scheduled

−$3.37M

34,505

0.0496%

$660.77K

+3,439%

James Leal

Chief Manufacturing Officer

—

$2.53M (15) scheduled

−$2.53M

16,876

0.0243%

$323.18K

+369.3%

Rebecca B Robertson

Director

—

$2.19M (17) scheduled

−$2.19M

22,542

0.0324%

$431.68K

—

Howard E Greene Jr

Director

$100.00K (1)

$1.70M (7)

−$1.60M

30,000

0.0431%

$574.50K

+154.5%

Peyton R Howell

Director

$240.19K (7)

—

+$240.19K

29,836

0.0429%

$571.36K

—

Jean-Claude Kyrillos

EVP & Chief Operating Officer

$190.97K (1)

—

+$190.97K

32,001

0.0460%

$612.82K

—

Richard P. Valencia

Director

$99.06K (2)

—

+$99.06K

3,054

0.0044%

$58.48K

—

Edward L Cahill

Director

—

$89.31K (1) scheduled

−$89.31K

23,274

0.0334%

$445.70K

−87.8%

Shannon Marie Hansen

EVP & Chief Legal Officer

$29.88K (1)

—

+$29.88K

33,585

0.0483%

$643.15K

—

Kathleen McGroddy-Goetz

Director

$21.45K (1)

$42.93K (1)

−$21.48K

26,612

0.0382%

$509.62K

—

Mark David Novara

EVP & Chief Commercial Officer

$12.36K (1)

$4.36K (2)

+$8.01K

40,317

0.0579%

$772.07K

—

John Cajigas

EVP, CFO & Treasurer

—

59,816

0.0860%

$1.15M

+22.1%

Rick Carpenter

EVP & Chief Technology Officer

—

32,148

0.0462%

$615.63K

—

Rajwant Sodhi

Director

—

24,280

0.0349%

$464.96K

—

Joao Paulo Falcao Malagueira

Director

—

22,458

0.0323%

$430.07K

—

Myoungil Cha

Director

—

22,458

0.0323%

$430.07K

—

TANDEM DIABETES CARE INC

What the insiders did Net selling

By person